![](/img/cover-not-exists.png)
ELOTUZUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: EFFICACY RESULTS AFTER ADDITIONAL FOLLOW-UP OF THE PHASE 2, RANDOMIZED ELOQUENT-3 STUDY
Dimopoulos, M., Dytfeld, D., Grosicki, S., Moreau, P., Takezako, N., Hori, M., Leleu, X., LeBlanc, R., Suzuki, K., Raab, M. S., Richardson, P. G., McKiver, Popa M., Jou, Y.-M., Shelat, S. G., Robbins,Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000563756.72895.a3
Date:
June, 2019
File:
PDF, 276 KB
2019